Literature DB >> 16611019

A literature review of enzyme kinetic parameters for CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes: structure-kinetics relationship assessment.

H-Z Bu1.   

Abstract

Cytochrome P450 (CYP) enzymes represent a superfamily of hemoproteins that are involved in the metabolism of a wide variety of endogenous and exogenous compounds. For a given CYP enzyme, kinetic properties of a substrate are usually related to substrate lipophilicity (log P or log D(7.4)). In this review, enzyme kinetic parameters (K(m), V(max), and V(max)/K(m)) of 215 CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes were obtained from the literature, and lipophilicity values of the 113 drugs were calculated using the ACD/Labs 8.0 program. A low degree of K(m)- or (V(max)/K(m))-lipophilicity correlation, but no V(max)-lipophilicity correlation, is exhibited for the CYP3A4-mediated reactions. Overall, K(m) decreases, but V(max)/K(m) increases, with increasing substrate lipophilicity, and V(max) appears to be independent of substrate lipophilicity. In other words, a low K(m) generally confers a high V(max)/K(m) ratio for a substrate. The degree of lipophilicity-kinetics correlations is related to both reaction types (or reaction mechanisms) and regiochemical positions (or physicochemical properties) of the reaction groups of the substrates. Among the categorized CYP3A4-mediated reactions, the best lipophilicity-kinetics correlation is achieved for carbon hydroxylation, followed by N-dealkylation. No or little lipophilicity-kinetics correlations are seen for N, S-oxidation and other reactions. Within the hydroxylation group, aliphatic hydroxylation shows the best lipophilicity-kinetics correlation while hydroxylation on a carbon atom adjacent to an aromatic ring does not show any lipophilicity-kinetics correlation. The detailed structural and kinetic data sets of the human liver microsomal CYP3A4-mediated reactions represent a specialized database useful for researchers working in the area of structure-metabolism relationship modeling and analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611019     DOI: 10.2174/138920006776359329

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  16 in total

1.  Heterologous expression of human cytochromes P450 2D6 and CYP3A4 in Escherichia coli and their functional characterization.

Authors:  Yan Pan; Badrul Amini Abd-Rashid; Zakiah Ismail; Rusli Ismail; Joon Wah Mak; Chin Eng Ong
Journal:  Protein J       Date:  2011-12       Impact factor: 2.371

2.  DEC1 binding to the proximal promoter of CYP3A4 ascribes to the downregulation of CYP3A4 expression by IL-6 in primary human hepatocytes.

Authors:  Mao Zhao; Luan Xiaofei; Cao Gang; Liu Wei; Xiong Jing; Hu Gang; Chen Ruini; Ning Rui; Shang Wei; Yang Jian; Yan Bingfang
Journal:  Biochem Pharmacol       Date:  2012-06-21       Impact factor: 5.858

3.  Tales from the war on error: the art and science of curating QSAR data.

Authors:  Marvin Waldman; Robert Fraczkiewicz; Robert D Clark
Journal:  J Comput Aided Mol Des       Date:  2015-08-20       Impact factor: 3.686

4.  Predictions of metabolic drug-drug interactions using physiologically based modelling: Two cytochrome P450 3A4 substrates coadministered with ketoconazole or verapamil.

Authors:  Nathalie Perdaems; Helene Blasco; Cedric Vinson; Marylore Chenel; Sarah Whalley; Fanny Cazade; François Bouzom
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

5.  Accounting for inter-correlation between enzyme abundance: a simulation study to assess implications on global sensitivity analysis within physiologically-based pharmacokinetics.

Authors:  Nicola Melillo; Adam S Darwich; Paolo Magni; Amin Rostami-Hodjegan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-03-23       Impact factor: 2.745

6.  Variance based global sensitivity analysis of physiologically based pharmacokinetic absorption models for BCS I-IV drugs.

Authors:  Nicola Melillo; Leon Aarons; Paolo Magni; Adam S Darwich
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-12-14       Impact factor: 2.745

7.  Characterization of T-5 N-oxide formation as the first highly selective measure of CYP3A5 activity.

Authors:  Xiaohai Li; Valer Jeso; Scott Heyward; Gregory S Walker; Raman Sharma; Glenn C Micalizio; Michael D Cameron
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

Review 8.  FXR signaling in the enterohepatic system.

Authors:  Tsutomu Matsubara; Fei Li; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2012-05-17       Impact factor: 4.102

9.  Metabolic pathway profiling of the derivative of important herbal component noscapine.

Authors:  Yonghua Yao; Yang Xiong
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-10-22       Impact factor: 2.441

10.  Monocrotophos Induces the Expression of Xenobiotic Metabolizing Cytochrome P450s (CYP2C8 and CYP3A4) and Neurotoxicity in Human Brain Cells.

Authors:  Vinay Kumar Tripathi; Vivek Kumar; Ankita Pandey; Pankhi Vatsa; Anupam Dhasmana; Rajat Pratap Singh; Sri Hari Chandan Appikonda; Inho Hwang; Mohtashim Lohani
Journal:  Mol Neurobiol       Date:  2016-05-20       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.